Antiepileptogenesis in humans: disappointing clinical evidence and ways to move forward.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Current Opinion in Neurology

• Publication date

  2014-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/WCO.0000000000000067PMID 24556736
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epilepsy therapy development: Technical and methodologic issues in studies with animal models

  2013cited by this paper
• Antiepileptic drugs for the primary and secondary prevention of seizures after subarachnoid haemorrhage.

  2013cited by this paper
• Anti-epileptogenesis: Electrophysiology, diffusion tensor imaging and behavior in a genetic absence model.

  2013cited by this paper
• Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI).

  2013cited by this paper
• Defining "epileptogenesis" and identifying "antiepileptogenic targets" in animal models of acquired temporal lobe epilepsy is not as simple as it might seem.

  2013cited by this paper
• Issues related to symptomatic and disease‐modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy

  2013cited by this paper
• Issues related to development of new antiseizure treatments

  2013cited by this paper
• Issues related to development of antiepileptogenic therapies

  2013cited by this paper
• Issues for new antiepilepsy drug development.

  2013cited by this paper
• A survey of adult and pediatric epilepsy surgery in the United Kingdom

  2013cited by this paper
• Ethosuximide reduces epileptogenesis and behavioral comorbidity in the GAERS model of genetic generalized epilepsy

  2013cited by this paper
• Joint AES/ILAE translational workshop to optimize preclinical epilepsy research

  2013cited by this paper
• Epilepsy biomarkers

  2013cited by this paper
• Development of new treatment approaches for epilepsy: Unmet needs and opportunities

  2013cited by this paper
• Proposal for a “phase II” multicenter trial model for preclinical new antiepilepsy therapy development

  2013cited by this paper
• Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme.

  2013cited by this paper
• A prospective multicenter comparison of levetiracetam versus phenytoin for early posttraumatic seizure prophylaxis

  2013cited by this paper
• Invasive EEG studies in tumor‐related epilepsy: When are they indicated and with what kind of electrodes?

  2013cited by this paper
• New avenues for anti-epileptic drug discovery and development

  2013cited by this paper
• Valproic acid use during radiation therapy for glioblastoma associated with improved survival.

  2012cited by this paper
• Mammalian Target of Rapamycin (mTOR) Inhibition: Potential for Antiseizure, Antiepileptogenic, and Epileptostatic Therapy

  2012cited by this paper
• Use of anterior temporal lobectomy for epilepsy in a community-based population.

  2012cited by this paper
• Effect of valproic acid on the outcome of glioblastoma multiforme

  2012cited by this paper
• GABAergic excitation after febrile seizures induces ectopic granule cells and adult epilepsy

  2012cited by this paper
• Epilepsy surgery trends in the United States, 1990–2008

  2012cited by this paper
• Anti-epileptic drugs for preventing seizures following acute traumatic brain injury.

  2012cited by this paper
• Clinical features of late-onset poststroke seizures.

  2012cited by this paper
• Is antiepileptogenesis a realistic goal in clinical trials? Concerns and new horizons

  2012cited by this paper
• Identification of new epilepsy treatments: Issues in preclinical methodology

  2012cited by this paper
• Effects of early long‐term treatment with antiepileptic drugs on development of seizures and depressive‐like behavior in a rat genetic absence epilepsy model

  2011cited by this paper
• Cost-utility analysis of levetiracetam and phenytoin for posttraumatic seizure prophylaxis.

  2011cited by this paper
• Therapeutic potential of new antiinflammatory drugs

  2011cited by this paper
• Mechanisms of epileptogenesis and potential treatment targets.

  2011cited by this paper
• Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma

  2011cited by this paper
• The role of inflammation in epilepsy

  2011cited by this paper
• Human clinical trails in antiepileptogenesis.

  2011cited by this paper
• Early treatment after stroke for the prevention of late epileptic seizures: a report on the problems performing a randomised placebo-controlled double-blind trial aimed at anti-epileptogenesis.

  2011cited by this paper
• Therapeutic approaches to epileptogenesis—Hope on the horizon

  2010cited by this paper
• Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.

  2010cited by this paper
• Prevention or Modification of Epileptogenesis after Brain Insults: Experimental Approaches and Translational Research

  2010cited by this paper
• Newly diagnosed single unprovoked seizures and epilepsy in Stockholm, Sweden: First report from the Stockholm Incidence Registry of Epilepsy (SIRE)

  2009cited by this paper
• Preventing and treating posttraumatic seizures: The human experience

  2009cited by this paper
• Emerging concepts in the pathogenesis of epilepsy and epileptogenesis.

  2009cited by this paper
• Comparison of the antiepileptogenic effects of an early long‐term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy

  2009cited by this paper
• Early treatment suppresses the development of spike‐wave epilepsy in a rat model

  2008cited by this paper
• Antiepileptic drugs for preventing seizures in people with brain tumors.

  2008cited by this paper
• Hippocampal epileptogenesis in animal models of mesial temporal lobe epilepsy with hippocampal sclerosis: The importance of the “latent period” and other concepts

  2008cited by this paper
• Optimizing therapy of seizures in patients with brain tumors

  2006cited by this paper
• Apathy does not equal depression in Parkinson disease

  2006cited by this paper
• Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumours

  2005cited by this paper
• NKCC1 transporter facilitates seizures in the developing brain

  2005cited by this paper
• Treating seizures in patients with brain tumors: Drug interactions between antiepileptic and chemotherapeutic agents.

  2003cited by this paper
• Prophylactic Anticonvulsants in Patients with Brain Tumour

  2003cited by this paper
• Overview of Studies to Prevent Posttraumatic Epilepsy

  2003cited by this paper
• On the Origin of Interictal Activity in Human Temporal Lobe Epilepsy in Vitro

  2002cited by this paper
• Antiepileptogenesis and Seizure Prevention Trials with Antiepileptic Drugs: Meta‐Analysis of Controlled Trials

  2001cited by this paper
• A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors

  1996cited by this paper
• Cooperative Prospective Study on Posttraumatic Epilepsy: Risk Factors and the Effect of Prophylactic Anticonvulsant

  1992cited by this paper
• Neurobehavioral effects of phenytoin prophylaxis of posttraumatic seizures.

  1991cited by this paper
• [Prevention of late post-traumatic epilepsy by phenytoin in severe brain injuries. 2 years' follow-up].

  1991cited by this paper
• A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures.

  1990cited by this paper
• Prophylactic anticonvulsants for prevention of immediate and early postcraniotomy seizures.

  1989cited by this paper
• Erythema multiforme and Stevens‐Johnson syndrome in patients receiving cranial irradiation and phenytoin

  1988cited by this paper
• Phenytoin and postoperative epilepsy. A double-blind study.

  1983cited by this paper
• Failure of prophylactically administered phenytoin to prevent late posttraumatic seizures.

  1983cited by this paper
• Failure of prophylactically administered phenytoin to prevent post-traumatic seizures in children.

  1983cited by this paper
• Low risk of late post-traumatic seizures following severe head injury: implications for clinical trials of prophylaxis.

  1983cited by this paper
• [Seizure prevention using carbamazepine following severe brain injuries].

  1983cited by this paper
• Failure of prophylactically administered phenytoin to prevent early posttraumatic seizures.

  1983cited by this paper
• TREATMENT FOR ACHALASIA

  1976cited by this paper
• Early traumatic epilepsy. Definition and identity.

  1969cited by this paper
• TRAUMATIC EPILEPSY AFTER CLOSED HEAD INJURIES*

  1960cited by this paper

• Safety and efficacy of eslicarbazepine acetate for seizure prevention in patients with stroke at high risk of developing post-stroke epilepsy: a proof-of-concept, phase 2a, randomised, double-blind, placebo-controlled antiepileptogenesis trial.

  2026cites this paper
• Areas of research priorities in epilepsy: A position paper of the European Reference Network for Rare and Complex Epilepsies, EpiCARE

  2026cites this paper
• Pharmacological strategies for preventing post-stroke seizures and epilepsy

  2026cites this paper
• Characteristics of and risk factors for epilepsy after autoimmune and infectious encephalitis

  2026cites this paper
• Precision medicine for epilepsy: challenges and perspectives for an optimized clinical care pathway

  2025cites this paper
• Epilepsy as a dynamic disease: Toward actionable, individualized seizure risk prediction

  2025cites this paper
• Treatment options for post-traumatic epilepsy: an update on clinical and translational aspects

  2025cites this paper
• Primary prophylaxis of seizures in post-hemorrhagic stroke rehabilitation patients.

  2025cites this paper
• Dual-outcome Prediction of Post-Ischemic Stroke Epilepsy and Mortality Using Multimodal Quantitative Biomarkers

  2025cites this paper
• Which terms should be used to describe medications used in the treatment of seizure disorders? An ILAE position paper

  2024cites this paper
• Innovative drug discovery strategies in epilepsy: integrating next-generation syndrome-specific mouse models to address pharmacoresistance and epileptogenesis

  2024cites this paper
• It's About Time! Timing in Epilepsy Evaluation and Treatment.

  2024cites this paper
• Prevention of epileptogenesis - are we there yet?

  2024cites this paper
• Highlights From the Annual Meeting of the American Epilepsy Society 2022

  2023cites this paper
• Acute symptomatic seizures after stroke: A scoping review on primary prevention, treatment with antiseizure medications and drug discontinuation.

  2023cites this paper
• A Leading Cause of Epilepsy

  2023cites this paper
• Natural product-derived therapies for treating drug-resistant epilepsies: From ethnopharmacology to evidence-based medicine.

  2023cites this paper
• Antiepileptogenesis after stroke—trials and tribulations: Methodological challenges and recruitment results of a Phase II study with eslicarbazepine acetate

  2023cites this paper
• Efficacy and safety of antiseizure medication in post-stroke epilepsy.

  2022cites this paper
• Approach to the Medical Treatment of Epilepsy

  2022cites this paper
• Diagnosis and Treatment of Poststroke Epilepsy: Where Do We Stand?

  2022cites this paper
• Incidence and Antiseizure Medications of Post-stroke Epilepsy in Umbria: A Population-Based Study Using Healthcare Administrative Databases

  2022influential citation
• A companion to the preclinical common data elements for phenotyping seizures and epilepsy in rodent models. A report of the TASK3‐WG1C: Phenotyping working group of the ILAE/AES joint translational task force

  2022cites this paper
• Seizures and Epilepsy After Stroke: Epidemiology, Biomarkers and Management

  2021cites this paper
• NDT_A_256699 2229..2242

  2021cites this paper
• Post-stroke seizure risk prediction models: a systematic review and meta-analysis.

  2021cites this paper
• Impact of drug treatment and drug interactions in post-stroke epilepsy.

  2021cites this paper
• New approaches for developing multi-targeted drug combinations for disease modification of complex brain disorders. Does epilepsy prevention become a realistic goal?

  2021cites this paper
• Antiepileptogenesis and disease modification: Clinical and regulatory issues

  2021cites this paper
• Clinical Management of Drug Resistant Epilepsy: A Review on Current Strategies

  2021cites this paper
• Amazon rainforest rodents (Proechimys) are resistant to post-stroke epilepsy

  2021cites this paper
• Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy

  2021cites this paper
• Cerebrovascular Disease; A Leading Cause of Epilepsy

  2020cites this paper
• The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments.

  2020cites this paper
• Time to Start Calling Things by Their Own Names? The Case for Antiseizure Medicines

  2020cites this paper
• A systematic review and indirect treatment comparison of perampanel versus brivaracetam as adjunctive therapy in patients with focal-onset seizures with or without secondary generalization.

  2020cites this paper
• How to diagnose and treat post-stroke seizures and epilepsy.

  2020cites this paper
• Statins in primary prevention of poststroke seizures and epilepsy: A systematic review.

  2020cites this paper
• Is the mechanism of action of antiseizure drugs a key element in the choice of treatment?

  2020cites this paper
• Development of an antiepileptogenesis drug screening platform: Effects of everolimus and phenobarbital

  2020cites this paper
• Drug Development for Rare Paediatric Epilepsies: Current State and Future Directions

  2019cites this paper
• High glucose concentrations mask cellular phenotypes in a stem cell model of tuberous sclerosis complex

  2019cites this paper
• Neurostimulation in the treatment of refractory and super-refractory status epilepticus.

  2019cites this paper
• Efficacy of perioperative anticonvulsant prophylaxis in seizure-naïve glioma patients: A meta-analysis.

  2019cites this paper
• Psychiatric aspects of posttraumatic epilepsy: A still unexplored area.

  2019cites this paper
• Regulatory aspects of status epilepticus

  2018cites this paper
• Selecting the appropriate pharmacotherapy for epilepsy in patients with Alzheimer’s disease

  2018cites this paper
• Randomized controlled trials of antiepileptic drugs for the treatment of post-stroke seizures: A systematic review with network meta-analysis.

  2018cites this paper
• Dysregulated Glucose Metabolism as a Therapeutic Target to Reduce Post-traumatic Epilepsy

  2018cites this paper
• Identification of brain regions predicting epileptogenesis by serial [18F]GE-180 positron emission tomography imaging of neuroinflammation in a rat model of temporal lobe epilepsy

  2017influential citation
• Overexpressing wild‐type γ2 subunits rescued the seizure phenotype in Gabrg2+/Q390X Dravet syndrome mice

  2017cites this paper
• Clinical studies and anti‐inflammatory mechanisms of treatments

  2017cites this paper
• Methodological issues associated with clinical trials in epilepsy

  2017cites this paper
• A systems level analysis of epileptogenesis-associated proteome alterations.

  2017cites this paper
• From Cannabis to Cannabidiol to Treat Epilepsy, Where Are We?

  2016cites this paper
• Upholding WAG/Rij rats as a model of absence epileptogenesis: Hidden mechanisms and a new theory on seizure development.

  2016cites this paper
• Novel treatment perspectives from advances in understanding of genetic epilepsy syndromes

  2016cites this paper
• Development of epilepsy after ischaemic stroke.

  2016cites this paper
• Challenges in the clinical development of new antiepileptic drugs.

  2016cites this paper
• Epilepsy: Trends in new-onset epilepsy — the importance of comorbidities

  2016cites this paper
• Exploring novel AEDs from drugs used for treatment of non-epileptic disorders

  2016cites this paper
• mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis.

  2016cites this paper
• Antiepileptogenese nach experimentellem Status epilepticus: Evaluation der Hypothermie

  2015cites this paper
• Disease Modification in Epilepsy: From Animal Models to Clinical Applications

  2015cites this paper
• Gender issues in antiepileptogenic treatments.

  2014cites this paper
• Hypothermia did not prevent epilepsy following experimental status epilepticus.

  2014cites this paper
• Antiepileptic Drug Use in Stroke-Related Seizures: Efficacy and Safety

  year unknowncites this paper